# Yuhan Chemical Inc., Hwaseong, Korea (the Republic of) – FDA Inspections

Source: https://www.keypedia.com/companies/yuhan-chemical-inc/e849010a-40f7-445b-9bc8-de7e15900a80

> Inspection records and compliance data for Yuhan Chemical Inc. in Hwaseong. 3 FDA inspections on record, 1 Form 483, last inspected January 12, 2024.

---

## Details

- Name: Yuhan Chemical Inc.
- FEI Number: 3008853591
- Address Line 1: 162 Cheongwonsandan8-Gil, Mado-Myeon
- City: Hwaseong
- Country Name: Korea (the Republic of)
- Address: 162 Cheongwonsandan8-Gil, Mado-Myeon, Hwaseong, Korea (the Republic of)
- Country: Korea (the Republic of)

## Related Documents

- [483 - Yuhan Chemical Inc. - 2024-01-12](https://www.keypedia.com/records/483/yuhan-chemical-inc/f9cec592-4f35-411e-a903-f0bc3a806e3b) — source: FDA, date: January 12, 2024
- FDA Inspection 1230864 - Yuhan Chemical Inc. - 2024-01-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 12, 2024
- FDA Inspection 1071578 - Yuhan Chemical Inc. - 2018-11-01 — classification: No Action Indicated (NAI), source: FDA, date: November 1, 2018
- [FDA Inspection 1014265 - Yuhan Chemical Inc. - 2017-05-19](https://www.keypedia.com/records/fda_inspections/yuhan-chemical-inc/bebe27bd-d0f9-4673-8174-84fddca31115) — source: FDA, date: May 19, 2017

## Related Companies

- [Pfizer Asia Manufacturing Pte Ltd.](https://www.keypedia.com/companies/pfizer-asia-manufacturing-pte-ltd/77c4ecfd-af67-404b-8091-9c254525198b)
- [AmbioPharm, Inc](https://www.keypedia.com/companies/ambiopharm-inc/6a51f093-2f5b-433d-8e97-8e33820a50bf)
- [Sun Pharmaceutical Industries Ltd](https://www.keypedia.com/companies/sun-pharmaceutical-industries-ltd/771469b2-c59c-423e-9ae7-6ce113d3928a)
- [Meiji Seika Pharma Co., Ltd.](https://www.keypedia.com/companies/meiji-seika-pharma-co-ltd/9f210099-6346-4340-9f86-521eb46b2629)
- [Centaur Pharmaceuticals Private Ltd.](https://www.keypedia.com/companies/centaur-pharmaceuticals-private-ltd/f96f4f92-5b20-4b5d-91d8-5b0dbe430494)
- [Divi's Laboratories Ltd. (Unit II)](https://www.keypedia.com/companies/divis-laboratories-ltd-unit-ii/b2498cb9-d277-498a-b32b-037e04f6feaf)
- [Auro Peptides Limited](https://www.keypedia.com/companies/auro-peptides-limited/4b0dd862-e510-4737-9a98-522e70a98627)
- [Lonza Biologics Porrino SL](https://www.keypedia.com/companies/lonza-biologics-porrino-sl/d45fc8fa-ae67-4a12-8cc5-193f3d428984)
- [AGILENT TECHNOLOGIES INC./US](https://www.keypedia.com/companies/agilent-technologies-incus/f39880d4-233e-44bc-9a9e-56d1f9b48065)
- [Laurus Labs Limited](https://www.keypedia.com/companies/laurus-labs-limited/5b25ff33-3634-4c5a-ad0c-2a1dba0c1efb)

## Related Officers

- [Senior CSO, Investigator](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)
- [Drug Discovery and Biotech Executive](https://www.keypedia.com/people/lloyd-d-payne/8b98c38a-4fbe-465d-bb0a-689bcc6db702)